BQS ORGANIC BLIND SAMPLES |
11-KETOTESTOSTERONE, |
Schedule: 4434 Testid: 64527GM005 |
Measured in |
06/19/08 TO 11/07/12 |
Open Data Set |
Statistics for the Plotted Points |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 108% | 21% | 108% | 22% |
>= Reporting Level | 8 | 79% | 19% | 72% | 23% |
Total | 12 | 89% | 24% | 89% | 30% |
Miscellaneous Statistics for the Samples |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 12 | 71% | Spiked |
Estimated Values | 1 | 6% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 18% | Spiked |
Spiked | 17 | . | |
False Negatives | 2 | 12% | 2 out of 17 |
Not Spiked | 95 | . | |
False Positives | 1 | 1% | 1 out of 94 |
BQS ORGANIC BLIND SAMPLES |
17-ALPHA-ESTRADIOL, |
Schedule: 4434 Testid: 64528GM005 |
Measured in |
01/16/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 53 | 87% | 14% | 88% | 11% |
Total | 53 | 87% | 14% | 88% | 11% |
Miscellaneous Statistics for the Samples |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 53 | 98% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 54 | . | |
False Negatives | 1 | 2% | 1 out of 54 |
Not Spiked | 58 | . | |
False Positives | 0 | 0% | 0 out of 58 |
BQS ORGANIC BLIND SAMPLES |
17-ALPHA-ETHYNYLESTRADIOL, |
Schedule: 4434 Testid: 64529GM005 |
Measured in |
06/19/08 TO 12/18/12 |
Open Data Set |
Statistics for the Plotted Points |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 50 | 82% | 15% | 81% | 14% |
Total | 50 | 82% | 15% | 81% | 14% |
Miscellaneous Statistics for the Samples |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 50 | 93% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 54 | . | |
False Negatives | 3 | 6% | 3 out of 54 |
Not Spiked | 58 | . | |
False Positives | 0 | 0% | 0 out of 58 |
BQS ORGANIC BLIND SAMPLES |
17-BETA-ESTRADIOL, |
Schedule: 4434 Testid: 64530GM005 |
Measured in |
01/16/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 54 | 88% | 15% | 87% | 14% |
Total | 54 | 88% | 15% | 87% | 14% |
Miscellaneous Statistics for the Samples |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 54 | 100% | Spiked |
Estimated Values | 2 | 4% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 54 | . | |
False Negatives | 0 | 0% | 0 out of 54 |
Not Spiked | 58 | . | |
False Positives | 1 | 2% | 1 out of 58 |
BQS ORGANIC BLIND SAMPLES |
NORETHINDRONE, |
Schedule: 4434 Testid: 64531GM005 |
Measured in |
01/16/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 105% | . | 105% | 0% |
>= Reporting Level | 48 | 85% | 19% | 82% | 19% |
Total | 49 | 85% | 19% | 83% | 19% |
Miscellaneous Statistics for the Samples |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 49 | 91% | Spiked |
Estimated Values | 7 | 13% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 54 | . | |
False Negatives | 5 | 9% | 5 out of 54 |
Not Spiked | 58 | . | |
False Positives | 0 | 0% | 0 out of 57 |
BQS ORGANIC BLIND SAMPLES |
3-BETA-COPROSTANOL, |
Schedule: 4434 Testid: 64532GM005 |
Measured in |
01/16/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 46 | 102% | 32% | 94% | 28% |
Total | 46 | 102% | 32% | 94% | 28% |
Miscellaneous Statistics for the Samples |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 100% | Spiked |
Estimated Values | 3 | 7% | Spiked |
Deleted Values | 7 | 7% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 49 | . | |
False Negatives | 0 | 0% | 0 out of 46 |
Not Spiked | 52 | . | |
False Positives | 6 | 13% | 6 out of 48 |
BQS ORGANIC BLIND SAMPLES |
4-ANDROSTENE-3,17-DIONE, |
Schedule: 4434 Testid: 64533GM005 |
Measured in |
01/16/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 21 | 90% | 15% | 87% | 17% |
Total | 21 | 90% | 15% | 87% | 17% |
Miscellaneous Statistics for the Samples |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 21 | 95% | Spiked |
Estimated Values | 1 | 5% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 5% | Spiked |
Spiked | 22 | . | |
False Negatives | 0 | 0% | 0 out of 22 |
Not Spiked | 90 | . | |
False Positives | 2 | 2% | 2 out of 89 |
BQS ORGANIC BLIND SAMPLES |
CHOLESTEROL, |
Schedule: 4434 Testid: 64534GM005 |
Measured in |
01/16/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 46 | 108% | 33% | 99% | 16% |
Total | 46 | 108% | 33% | 99% | 16% |
Miscellaneous Statistics for the Samples |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 100% | Spiked |
Estimated Values | 2 | 4% | Spiked |
Deleted Values | 7 | 7% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 49 | . | |
False Negatives | 0 | 0% | 0 out of 46 |
Not Spiked | 52 | . | |
False Positives | 6 | 13% | 6 out of 48 |
BQS ORGANIC BLIND SAMPLES |
CIS-ANDROSTERONE, |
Schedule: 4434 Testid: 64535GM005 |
Measured in |
01/16/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 89% | 24% | 83% | 16% |
Total | 40 | 89% | 24% | 83% | 16% |
Miscellaneous Statistics for the Samples |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 95% | Spiked |
Estimated Values | 7 | 17% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 42 | . | |
False Negatives | 1 | 2% | 1 out of 42 |
Not Spiked | 70 | . | |
False Positives | 0 | 0% | 0 out of 69 |
BQS ORGANIC BLIND SAMPLES |
TRANS-DIETHYLSTILBESTROL, |
Schedule: 4434 Testid: 64536GM005 |
Measured in |
08/20/08 TO 12/18/12 |
Open Data Set |
Statistics for the Plotted Points |
TRANS-DIETHYLSTILBESTROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 80% | . | 80% | 0% |
>= Reporting Level | 51 | 70% | 18% | 66% | 19% |
Total | 52 | 70% | 18% | 67% | 19% |
Miscellaneous Statistics for the Samples |
TRANS-DIETHYLSTILBESTROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 52 | 90% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 6 | 10% | 6 out of 58 |
Not Spiked | 53 | . | |
False Positives | 0 | 0% | 0 out of 53 |
BQS ORGANIC BLIND SAMPLES |
EPITESTOSTERONE, |
Schedule: 4434 Testid: 64537GM005 |
Measured in |
01/16/08 TO 12/18/12 |
Open Data Set |
Statistics for the Plotted Points |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 58% | 18% | 52% | 5% |
>= Reporting Level | 34 | 89% | 23% | 85% | 18% |
Total | 39 | 85% | 25% | 82% | 19% |
Miscellaneous Statistics for the Samples |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 100% | Spiked |
Estimated Values | 8 | 21% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 72 | . | |
False Positives | 2 | 3% | 2 out of 72 |
BQS ORGANIC BLIND SAMPLES |
EQUILENIN, |
Schedule: 4434 Testid: 64538GM005 |
Measured in |
06/09/08 TO 11/07/12 |
Open Data Set |
Statistics for the Plotted Points |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 38 | 71% | 29% | 74% | 26% |
Total | 38 | 71% | 29% | 74% | 26% |
Miscellaneous Statistics for the Samples |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 90% | Spiked |
Estimated Values | 10 | 24% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 42 | . | |
False Negatives | 3 | 7% | 3 out of 42 |
Not Spiked | 41 | . | |
False Positives | 4 | 10% | 4 out of 41 |
BQS ORGANIC BLIND SAMPLES |
EQUILIN, |
Schedule: 4434 Testid: 64539GM005 |
Measured in |
06/09/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
EQUILIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 71% | 18% | 64% | 1% |
>= Reporting Level | 42 | 68% | 29% | 68% | 19% |
Total | 47 | 68% | 28% | 66% | 19% |
Miscellaneous Statistics for the Samples |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 47 | 80% | Spiked |
Estimated Values | 47 | 80% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 61 | . | |
False Negatives | 11 | 19% | 11 out of 59 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 51 |
BQS ORGANIC BLIND SAMPLES |
ESTRIOL, |
Schedule: 4434 Testid: 64540GM005 |
Measured in |
08/14/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 9 | 96% | 41% | 84% | 9% |
>= Reporting Level | 49 | 81% | 21% | 78% | 17% |
Total | 58 | 83% | 26% | 80% | 18% |
Miscellaneous Statistics for the Samples |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 88% | Spiked |
Estimated Values | 11 | 17% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 5% | Spiked |
Spiked | 67 | . | |
False Negatives | 5 | 8% | 5 out of 66 |
Not Spiked | 45 | . | |
False Positives | 3 | 7% | 3 out of 45 |
BQS ORGANIC BLIND SAMPLES |
ESTRONE, |
Schedule: 4434 Testid: 64541GM005 |
Measured in |
06/09/08 TO 12/18/12 |
Open Data Set |
Statistics for the Plotted Points |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 56 | 98% | 26% | 94% | 25% |
Total | 56 | 98% | 26% | 94% | 25% |
Miscellaneous Statistics for the Samples |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 95% | Spiked |
Estimated Values | 5 | 8% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 2 | 3% | Spiked |
Spiked | 59 | . | |
False Negatives | 1 | 2% | 1 out of 59 |
Not Spiked | 53 | . | |
False Positives | 0 | 0% | 0 out of 52 |
BQS ORGANIC BLIND SAMPLES |
MESTRANOL, |
Schedule: 4434 Testid: 64542GM005 |
Measured in |
06/09/08 TO 12/18/12 |
Open Data Set |
Statistics for the Plotted Points |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 143% | . | 143% | 0% |
>= Reporting Level | 53 | 82% | 46% | 69% | 26% |
Total | 54 | 83% | 46% | 69% | 28% |
Miscellaneous Statistics for the Samples |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 54 | 92% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 3% | Spiked |
Spiked | 59 | . | |
False Negatives | 3 | 5% | 3 out of 59 |
Not Spiked | 53 | . | |
False Positives | 0 | 0% | 0 out of 53 |
BQS ORGANIC BLIND SAMPLES |
PROGESTERONE, |
Schedule: 4434 Testid: 64543GM005 |
Measured in |
06/09/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
PROGESTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 15 | 84% | 42% | 87% | 33% |
>= Reporting Level | 35 | 57% | 26% | 51% | 11% |
Total | 50 | 65% | 34% | 52% | 27% |
Miscellaneous Statistics for the Samples |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 50 | 82% | Spiked |
Estimated Values | 50 | 82% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 9 | 15% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 51 |
BQS ORGANIC BLIND SAMPLES |
DIHYDROTESTOSTERONE, |
Schedule: 4434 Testid: 64544GM005 |
Measured in |
08/14/08 TO 02/08/13 |
Open Data Set |
Statistics for the Plotted Points |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 142% | 54% | 156% | 85% |
>= Reporting Level | 15 | 70% | 35% | 66% | 8% |
Total | 26 | 100% | 56% | 71% | 67% |
Miscellaneous Statistics for the Samples |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 26 | 96% | Spiked |
Estimated Values | 8 | 30% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 4% | Spiked |
Spiked | 27 | . | |
False Negatives | 0 | 0% | 0 out of 27 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
BQS ORGANIC BLIND SAMPLES |
TESTOSTERONE, |
Schedule: 4434 Testid: 64545GM005 |
Measured in |
08/14/08 TO 12/18/12 |
Open Data Set |
Statistics for the Plotted Points |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 25 | 94% | 17% | 90% | 12% |
Total | 25 | 94% | 17% | 90% | 12% |
Miscellaneous Statistics for the Samples |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 25 | 100% | Spiked |
Estimated Values | 2 | 8% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 0 | 0% | 0 out of 25 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 86 |
BQS ORGANIC BLIND SAMPLES |
BISPHENOL A, |
Schedule: 4434 Testid: 67305GM005 |
Measured in |
02/01/10 TO 11/01/12 |
Open Data Set |